TheEdgeResearch
Home / Stocks / XTXXF

Adastra Holdings Ltd. (XTXXF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.01 ▲ +0.00%
Market Cap
$39,179
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-0.51
52-Wk Range
0.007-0.02
CEO
Brian O'Neill
Country
CA
Currency
USD

Adastra Holdings Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Langley, BC, CA. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $39,179. On trailing twelve-month figures it carries a trailing P/E of -0.67, a net margin of -22.4%. Its beta of -0.51 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.67
Price / Sales
0.15
Price / Book
-1.18
EV / EBITDA
-3.99
Gross margin
31.5%
Operating margin
-16.0%
Net margin
-22.4%
Return on equity
—
Debt / equity
-3.77
Current ratio
0.38
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
21
IPO date
2021-07-19
Headquarters
Langley, BC, CA
About Adastra Holdings Ltd.

Adastra Holdings Ltd. is a company specializing in solutions for cannabis processing and extraction. It provides a variety of services, including comprehensive analytical testing and processing for cannabis. The company offers its processing expertise to licensed cultivators of both cannabis and hemp. Additionally, it supplies cannabis extracts to qualified business-to-business partners, serving both Canadian and international markets. Formed in 1987, Adastra Holdings Ltd. adopted its current name in September 2021, having previously been known as Phyto Extractions Inc. The company's headquarters are located in Langley, Canada.

Comparable companies

Adastra Holdings Ltd. is most often compared with the following Healthcare names:

ACUSADVTBBBTCANLNEPTFNXENREZNFSONXTRCNFWRHLF
More research on XTXXF
XTXXF technical analysis XTXXF TheEdge Score Compare against peers
Open full interactive analysis & DCF →